# Broadhi Capital

> Broadhi Capital is a VC fund in Shanghai backing Health Care, Medical and Mobile. See 16 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 16
- Last investment: Nov 2020
- Lead investor: 13%
- Last fund: Jan 2017
- Last updated: Aug 2026
- Website: http://www.beyondfund.com/

Broadhi Capital is a venture capital and private equity firm specializing in growth and mature stage investments. For mature companies, the firm seeks to invest in firms that are in Pre-IPO stage and can be listed in an IPO within 2-3 years. For growth companies, it seeks to invest in firms that can be listed in an IPO within 1-3 years. The firmprefers to invest in biomedical, biotechnology, new consumer, energy conservation, clean technology, new materials, advanced manufacturing, medical treatment, environment protection, electronic information technology, energy saving, equipment, consumer, new materials, and modern agriculture industry. It typically invests in companies based in China, especially in Henan Province. The firm seeks to have a minority stake of 35% or lower in their portfolio companies. Broadhi Capital was founded on July 2008 and is based in Shanghai, China with additional offices in Beijing, China and Zhengzhou, China.

## Round sizes

| Stage | Round size |
| --- | --- |
| Angel | $68k–$752k |
| Series A | $221k–$43M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 7 | 44% |
| Medical | 6 | 38% |
| Mobile | 4 | 25% |
| Manufacturing | 4 | 25% |
| Agriculture | 2 | 13% |

25 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Angel | 5 | 31% |
| Series A | 5 | 31% |
| Series B | 2 | 13% |
| Seed | 1 | 6% |
| Series C | 1 | 6% |

6 stages tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Abiochem Biotechnology | Abiochem Biotechnology is a high-tech enterprise with leading enzyme engineering technology and genetic engineering technology. Engaged in the research and development of biocatalytic and synthetic biology methods, and is committed to its application to large-scale production. It is widely used in the fields of medicine, health care products,pesticides, etc., and has contributed to the promotion and development of green chemistry. |  | Series A | Nov 28, 2020 |  |
| Abiochem Biotechnology | Abiochem Biotechnology is a high-tech enterprise with leading enzyme engineering technology and genetic engineering technology. Engaged in the research and development of biocatalytic and synthetic biology methods, and is committed to its application to large-scale production. It is widely used in the fields of medicine, health care products,pesticides, etc., and has contributed to the promotion and development of green chemistry. |  | Series A | Apr 03, 2019 |  |
| Thousand Oaks Biopharmaceuticals | Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. The company's technologies provide integrated control solutions, including the use of technical expertise to optimize the process and increase protein expression to reduce production scale, providingbio-pharmaceutical companies with personalized, chemical-defined cell culture media, formula production, technical support and ancillary services. | $42.5M | Series A | Jan 01, 2019 |  |
| Jin Yu Medical | Jinyu Medical focuses on remote clinics and family doctor services. |  | Seed | Oct 24, 2018 |  |
| Sinagri YingTai | Sinagri YingTai is a producer of green alternative products that conducts research and development in the fields of animal nutrition, biological veterinary medicine, biological medicine, health care products, cosmetics, and other fields. Their products include animal health, veterinary medicine, and raw materials. |  | Series B | Jul 23, 2018 |  |
| Fansheng Tuxiang | Fansheng Tuxiang company has a number of wholly-owned subsidiaries as well as R&D centers, laboratories, and offices. They offer a modular design and a tool-based application platform to quickly and affordably implement the laboratory standard in the mass production process. | $421K | Series B | Jul 20, 2016 |  |
| TM' Holter | TM' Holter is an application development of intelligent biosensing systems. | $221K | Series A | Oct 22, 2015 |  |
| Panther Healthcare | Panther Healthcare develops and manufactures surgical stapling and minimally invasive endo surgery products. | $15.2M | Series A | Jun 19, 2015 |  |
| Cooee Technology | Cooee Technology is a mobile game developer company. | $425K | Angel | May 29, 2015 |  |
| Uliaobao.com | uliaobao provides online sales of fabric products. They provide cotton, woolen blended fabrics, chemical fabrics, and others. They allow consumers to directly buy goods or services from a seller over the internet using a web browser or a mobile app. Their products serve consumers. | $752K | Angel | May 29, 2015 |  |

10 of 16 investments shown.

## Co-investors
- [Beiruan Angle](https://shizune.co/investors/profile/beiruan-tianshi-jijin) — VC Fund, 2 deals together
- [Huatai Zijin Investment](https://shizune.co/investors/profile/huatai-zijin-investment) — VC Fund, 2 deals together
- [Addor Capital](https://shizune.co/investors/profile/addor-capital) — VC Fund, 1 deal together
- [Blue Bay Science Capital](https://shizune.co/investors/profile/blue-bay-science-capital) — VC Fund, 1 deal together
- [Enwei Capital](https://shizune.co/investors/profile/enwei-capital) — VC Fund, 1 deal together
- [Haitong-Fortis Private Equity Fund Management](https://shizune.co/investors/profile/haitong-fortis-private-equity-fund-management) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [LVX Ventures](https://shizune.co/investors/profile/letsventure) — VC Fund
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund
- [IAN Group](https://shizune.co/investors/profile/indian-angel-network) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Mobile Investors in China](https://shizune.co/investors/mobile-investors-china)
- [Agriculture (agtech) Investors in Asia](https://shizune.co/investors/agriculture-agtech-investors-asia)
- [Agriculture (agtech) Investors in China](https://shizune.co/investors/agriculture-agtech-investors-china)
- [Agriculture (agtech) VC Funds in China](https://shizune.co/investors/agriculture-agtech-vc-funds-china)
- [Agriculture (agtech) Investors in China](https://shizune.co/investors/agriculture-agtech-investors-china)
- [Agriculture (agtech) VC Funds in China](https://shizune.co/investors/agriculture-agtech-vc-funds-china)

## FAQ

### What does Broadhi Capital invest in?

Broadhi Capital invests primarily in Health Care, Medical and Mobile startups, most often at Angel and Series A stage. Most of the 16 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Broadhi Capital's check size?

Broadhi Capital typically joins rounds of $68k–$752k at Angel and $221k–$43M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Broadhi Capital participates in.

### When did Broadhi Capital last invest?

The most recent investment recorded for Broadhi Capital closed in Nov 2020. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co